Wilmington Savings Fund Society FSB Has $1.19 Million Stake in Solventum Co. (NYSE:SOLV)

Wilmington Savings Fund Society FSB boosted its stake in shares of Solventum Co. (NYSE:SOLV) by 196.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,062 shares of the company’s stock after buying an additional 11,312 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Solventum were worth $1,190,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SOLV. Deseret Mutual Benefit Administrators bought a new stake in shares of Solventum in the 2nd quarter valued at $25,000. Hollencrest Capital Management acquired a new stake in shares of Solventum during the 2nd quarter worth approximately $25,000. Richard W. Paul & Associates LLC bought a new position in Solventum during the second quarter worth $26,000. Family Firm Inc. acquired a new stake in Solventum in the second quarter worth $26,000. Finally, Copeland Capital Management LLC bought a new stake in Solventum in the third quarter valued at $26,000.

Wall Street Analyst Weigh In

SOLV has been the topic of a number of research analyst reports. Piper Sandler increased their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Stifel Nicolaus started coverage on Solventum in a report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective for the company. BTIG Research started coverage on Solventum in a report on Thursday, September 5th. They issued a “neutral” rating on the stock. Morgan Stanley boosted their price target on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Finally, Wolfe Research initiated coverage on shares of Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating on the stock. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, Solventum currently has a consensus rating of “Hold” and a consensus target price of $68.29.

Solventum Price Performance

Shares of NYSE:SOLV opened at $69.56 on Friday. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The stock’s fifty day simple moving average is $70.91 and its two-hundred day simple moving average is $63.22.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.